MicroRNAs are universal post-transcriptional regulators in genomes. They have the ability of buffering gene expressional programs, contributing to robustness of biological systems and playing important roles in development, physiology and diseases. Here, we identified a microRNA, miR-125a, as a positive regulator of granulopoiesis. MiR125a knockout mice show reduced infiltration of neutrophils in the lung and alleviated tissue destruction after endotoxin challenge as a consequence of decreased neutrophil numbers. Furthermore, we demonstrated that this significant reduction of neutrophils was due to impaired development of granulocyte precursors to mature neutrophils in an intrinsic manner. We showed that Socs3, a critical repressor for granulopoiesis, was a target of miR-125a. Overall, our study revealed a new microRNA regulating granulocyte development and supported a model in which miR-125a acted as a fine-tuner of granulopoiesis.
Neutrophils, also known as polymorphonuclear leukocytes (PMNs), are the most abundant granulocytes which play a crucial role in immune defense and inflammatory reaction. Given that the post-mitotic nature of mature neutrophils, they have short lives about only a few days [1] and need to be regenerated constantly through granulopoiesis, a part of hematopoiesis occurring in the bone marrow of adult mammals. During granulopoiesis, hematopoietic stem cells, at the top of the hematopoietic hierarchy, produce multilineage progenitors and precursors-common myeloid progenitors (CMP) and subsequently granulocyte-monocyte progenitors (GMP) which differentiate into mature granulocytes including eosinophils, basophils and neutrophils [2]. In general, granulopoiesis is in a basal physiological condition. However, emergency granulopoiesis can be rapidly induced to produce large number of neutrophils if severe systemic infection occurs [3]. Hematopoiesis is regulated by a group of cytokines. G-CSF is one of the major cytokine that regulates cell proliferation, differentiation and survival during the neutrophil lineage commitment [4,5]. The receptor of G-CSF is mainly expressed in granulocytic progenitor cells and mature neutrophils [6]. The binding of G-CSF to its receptor triggers receptor dimerization and tyrosine phosphorylation of JAK1, JAK2 and TYK2, which belong to the Janus family of protein tyrosine kinases (JAKs) [7]. These then phosphorylate residues in the cytosolic part of the G-CSF receptor and subsequently activate mitogen-activated protein (MAP) kinase like ERK pathway [8] and the signal transducers and activators of transcription (STATs) including STAT1 and STAT3 (4,10). SOCS3, as the major repressor of G-CSF signaling, belongs to the suppressor of cytokine signaling (SOCS) family of proteins [9], which can be recruited to phosphorylated cytokine receptors and inhibit JAK catalytic activity and subsequently inhibit activation of ERK and STATs. Moreover, mice with Socs3 conditionally knocked out in hematopoietic cells [10,11] develop neutrophilia and inflammatory pathologies. MicroRNAs (miRs or miRNAs) are universal post-transcriptional regulators in animals and plants. Primary miRNAs are first transcribed by RNA polymerase II or III and are then excised to mature miRNAs (~22 nucleotide) that bind to 3’ untranslated regions (UTR) of their target mRNAs to silence gene expression [12]. More than 1000 miRNA genes have been identified in mammalian genomes [13]. And over 60% of protein-coding genes could be targeted by miRNAs according to computational prediction [14]. Due to their specific features, miRNAs have the ability of buffering gene expression programs and contributing to the robustness of biological systems [15]. Thus they play important regulatory roles in different biological processes. Decades of researches have shown that miRNAs involve in mammalian blood cell development and function [16]. For instance, miR-181a was found to modulate T cell selection [17] and miR-150 was identified as a controller of B cell development [18–20] as well as megakaryocytic versus erythrocytic lineage commitment [21]. In addition, miR-223, which was found highly expressed in neutrophils, played a role in regulating the proliferation of granulocyte progenitors and also mediated the inflammatory function of neutrophils [22,23]. MiR-125a and miR-125b belong to the miR-125 family, which play a crucial role in many different cellular processes including cell differentiation, proliferation and apoptosis [24]. In order to systematically study the function of miR-125a in vivo, we developed miR-125a knockout mice. We examined the hematopoiesis of these mice and found fewer neutrophils in both bone marrow and peripheral blood in the absence of miR-125a. As a consequence of decreased number of neutrophils, MiR125a knockout mice were demonstrated with reduced infiltration of neutrophils in the lung and alleviated tissue destruction in an endotoxin challenge model. Furthermore, we found out that the reduction of neutrophils was due to impaired proliferation of immature granulocyte to mature neutrophils in an intrinsic manner. We showed that Socs3, a critical repressor for granulopoiesis, was a target of miR-125a. Together, these results suggest that miR-125a is an important regulator of basal granulopoiesis.
To fully understand the physiological role of miR-125a in vivo, we generated the MiR125a knockout mice as previously described [25]. These mice are fertile, born at the expected mendelian ratio, and not shown any abnormalities during their growth. However, we found that the white blood cell differential count revealed decreased numbers of neutrophils in MiR125a-/- mice (1. 4 ± 0. 3 x 106cells/mL versus 2. 2 ± 0. 4 x 106 cells/mL) (p<0. 0001) while other mature hematopoietic lineage cells including other granulocytes (eosinophils and basophils) were normal (Table 1). Flow cytometry analyses of neutrophils in the bone marrow and peripheral blood confirm these results (Fig 1A). Next we did a bone marrow transfer assay to find out whether reduced granulopoiesis in MiR125a-/- mice are due to impaired cell-autonomous development or altered cytokine production from the bone marrow stromal cells. We found that decreased number of neutrophils reconstituted with MiR125a-/- bone marrow cells was both in MiR125a+/+ and MiR125a-/- recipients (Fig 1B). These results demonstrate that miR-125a contributes to reduced granulopoiesis in a cell-autonomous way. In addition, morphological analysis shows that neutrophils in MiR125a-/- mice are as mature as those in wild-type mice (Fig 1C). We then examined the expression of miR-125a in different stages of myeloid development and found that miR-125a was highly expressed in hematopoietic stem cells and decreased during maturation of myeloid progenitor cells, indicating that miR-125a may be involved in regulating granulocyte development (Fig 1D). In order to examine whether miR-125a also plays a role in regulating neutrophil function, we tested the ability of activation, migration and killing pathogens between wild-type and MiR125a-/- neutrophils. Gene expression profiling data of bone marrow neutrophils stimulated with gram-negative bacterial lipopolysaccharide (LPS) showed that most of inflammatory factors and chemokines were induced equally either from MiR125a-/- or MiR125a+/+ mice (S1A Fig). Then in vitro transwell assay showed MiR125a-/- neutrophils had no detectable abnormality in fMLP or CXCL1 or CXCL2-dependent chemotaxis and migration (S1B Fig). We then used phorbol myristate acetate (PMA) or LPS to stimulate neutrophils and measured the production of reactive oxygen metabolites, which were important for neutrophils to kill pathogens. FACS analysis revealed no difference in the release of reactive oxygen species between wild-type and knock-out neutrophils (S1C Fig). Furthermore in vitro killing assay also demonstrated MiR125a-/- neutrophils had normal ability to clear bacteria and fungi (S1D Fig). Neutrophils are known to be recruited at inflammatory tissue sites and play a critical role in sepsis and tissue damage [26]. We therefore performed experimental endotoxaemia by injecting a sub-lethal intraperitoneal dose of LPS to MiR125a-/- mice for 24 hours and measured neutrophil infiltration in the lungs by flow cytometry. Lungs of MiR125a-/- mice accumulated fewer neutrophils than those of MiR125a+/+ mice (Fig 2A). In addition, we checked the lung sections of MiR125a-/- and wild-type mice. Consistently with the FACS analysis, lungs of MiR125a-/- mice show less severe histopathological change, including congestion (hyperplasia of alveolar walls and alveolar collapse), edema (pulmonary interstitial edema), inflammation (neutrophil infiltration) and hemorrhage (engorgement of the capillaries) (Fig 2B). We also found MiR125a-/- mice had significantly reduced serum amounts of aspartate aminotransferase (ALT), blood urea nitrogen (BUN), creatine kinase (CK) and creatinine (CREA), which were indicators for organ damages (Fig 2C). We next challenged both MiR125a-/- and wild-type mice with a lethal dose of LPS. We observed that MiR125a-/- mice were more resistant to lethal septic shock (Fig 2D). However, serum concentrations of inflammatory cytokine IL-6 and TNF-α during sepsis were similar (Fig 2E). In addition, normal Il6 and Tnfa mRNAs were expressed in peritoneal macrophages and bone marrow-derived macrophages after stimulation with LPS (S2 Fig). To further study whether there is any macrophage involvement, we depleted endogenous macrophages by using clodronate liposomes in wild-type mice and transplanted with MiR125a+/+ or MiR125a-/- bone marrow-derived macrophages. Then we administrated these mice with the lethal dose of LPS. Results did not show any difference in mortality (Fig 2F). These results implied that cytokine production induced by Toll-like receptors on macrophages did not contribute to resistance to LPS in MiR125a-/- mice. Thus resistance to a lethal dose of LPS and decreased neutrophils in the lungs with endotoxaemia in MiR125a-/- mice are likely caused by reduced granulopoiesis. To study the mechanism of decreased neutrophil numbers in MiR125a-/- mice, we performed flow cytometry analysis on bone marrow cells in both wild type (WT) and knockout (KO) mice to examine whether the frequency of progenitor cells was disturbed. We found that the numbers of myeloid progenitors did not change (Fig 3A). We then performed colony forming assays on methylcellulose and analyzed them for myeloid precursors in complete medium. There is no significant difference in the frequency of myeloid precursors and numbers of granulocyte colonies (Fig 3B). For greater precision, we performed colony assays in the medium only containing variant concentrations of G-CSF and found that there was also no change in colony numbers (Fig 3C). However, we did notice that colonies from mutant mice were smaller and the cell number in one colony was less than those found in control mice (S3 Fig). Thus we sorted Lin-Sca1-c-Kit+CD34hiCD16/32hi GMPs by FACS and estimated their developmental capacity in a CFU assay. We also found the colony number did not change (Fig 3D) but the colony size and the cell number per colony from MiR125a-deficient GMPs decreased in the presence of G-CSF (Fig 3E–3G). Thus, it suggested that the development of granulocyte progenitors might be impaired in MiR125a-/- mice. Since the number of granulocyte progenitors remained unchanged, it would appear that reduction of neutrophils only was due to increased cell death or impaired proliferation from granulocyte progenitors to mature neutrophils. To test the first possibility, we examined cell death rate of Ly6Ghi cells from bone marrow by staining them with Annexin V and propidium iodide. We found no difference in the rate of cell death between MiR125a-/- and wild-type mice (Fig 4A). We then performed in vivo BrdU-pulsing assays to analyze neutrophils generation in bone marrow (Fig 4B) and spleen (Fig 4C). Flow cytometry results showed that neutrophils from MiR125a-/- mice incorporated less BrdU than wild-type mice, indicating that cell proliferation had decreased during the differentiation of granulocyte progenitors into neutrophils. It has been reported that CD11b+ Gr-1+ neutrophils in bone marrow are composed of three populations, including CD11bhi Gr-1hi cells (mature Neu), CD11blowGr-1hi cells (immature Neu) and CD11bintGr-1int cells (promyelocytes/myelocytes) [27–29]. According to this, we found the percentage of immature neutrophils was significantly lower in the bone marrow of MiR125a-deficient mice while the percentages of promyelocytes/myelocytes and mature neutrophils had no change (Fig 5A). In addition, we found BrdU-incorporating cells in the population of immature and mature neutrophils were significantly lower in MiR125a KO mice compared with WT controls while the population of promyelocytes/myelocytes had no change (Fig 5B). Because of post-mitotic nature of mature neutrophils, these BrdU-incorporating mature neutrophils mostly came from BrdU-incorporating immature neutrophils during their last division. Thus we deduced that the neutropenia of MiR125a-deficient mice could be due to reduced cell proliferation of CD11blowGr-1hi immature neutrophils. As G-CSF is the major cytokine during granulocyte differentiation, we purified neutrophils from bone marrow cells and stimulated them with variant concentrations of G-CSF and counted the cell number after 24 hours. We found that the survival number of bone marrow neutrophils from wild-type mice increased substantially with increased G-CSF concentration while bone marrow neutrophils from MiR125a-/- mice did not increase in number (Fig 6A). We then analyzed apoptosis percentage and BrdU-incorporated cell ratios in response to G-CSF. In accordance with the observation in vivo, the amount of BrdU-incorporation was less in the absence of miR-125a (Fig 6B) while the apoptosis percentage has no change (Fig 6C). In addition, we found the mRNA levels of Gcsfr and several essential trancriptional factors for granulopoiesis like Pu. 1, Gata-1, Cebpa, Cebpb and Cebpe did not change (S4 Fig). These results suggest that decreased cell proliferation in MiR125a-deficient mice might be due to impaired G-CSF signaling. To investigate the molecular mechanism that contributes to impaired G-CSF-dependent proliferation, we examined activation of STAT1, ERK and STAT3 under the G-CSF signaling pathway (Fig 6D). In repeated experiments, we found that the ratio of phosphorylated STAT1, ERK and STAT3 vs. total STAT1, ERK and STAT3 was markedly weaker and less prolonged in different level in MiR125a-/- neutrophils in response to G-CSF (Fig 6E). This result indicates that the upstream in G-CSF signaling is impaired. However, we noticed that phospho-STAT3 was moderately enhanced while total STAT3 was much higher in MiR125a-/- bone marrow neutrophils. To determine whether the moderately enhanced p-STAT3 involves in mediating the decreased cell proliferation during maturation of MiR125a-/- GMPs, we cultured MiR125a-/- GMPs with G-CSF in the presence of STAT3 inhibitor S3I-201 or DMSO in CFU assays. Results show that inhibiting STAT3 cannot rescue the decelerated cell proliferation of MiR125a-/- GMP (S5A–S5C Fig). Therefore, according to these data, STAT3 is unlikely to mediate decreased granulocyte differentiation in MiR125a-/- mice. Due to impaired G-CSF signaling pathway in MiR125a-deficient mice, we deduced that miR-125a might target a repressor in this signaling. SOCS3 is the major suppressor of G-CSF signaling and neutrophils differentiation [10,30,31]. Furthermore, we indeed detected higher SOCS3 protein expression levels in purified neutrophils lacking miR-125a compared to wild-type (Fig 7A). Thus we tested whether miR-125a directly targeted Socs3. We firstly predicted possible target sites in 3’UTR of Socs3 by using RNAhybrid and RNA22, and we found miR-125a has a potential binding site in the 3’UTR of Socs3 (Fig 7B). Then to confirm whether Socs3 is targeted by miR-125a, we cloned the full length of the 3’UTR of Socs3 onto a construct fused to the renilla reporter gene and mutated the predicted seed sequences. We co-transfected these plasmids with synthetic miR-125a oligonucleotide or negative control oligonucleotide in 293T cells respectively. The results indicated that miR-125a suppressed renilla luciferase activity but the mutants completely inhibited the suppression of the renilla luciferase activity (Fig 7C). These results demonstrate that miR-125a directly targets Socs3. But there remains a question whether Socs3 is a true target of miR-125a to regualte granulopoiesis. To address this issue, we did rescue experiments as follows. Firstly, we used shRNA to knock down Socs3 expression in MiR125a-deficient bone marrow cells and then did CFU assays in the presence of G-CSF. Results are shown that knockdown of Socs3 decrease Socs3 mRNA expression (Fig 7D). And the colony size (Fig 7E) and the cell number per colony (Fig 7G) both increase after Socs3 knockdown. However, the colony number does not change (Fig 7F). Next, we did a in vivo rescue assay by isolating short-term hematopoietic stem cells (ST-HSCs) from the bone marrow of MiR125a knockout mice, and we transduced these ST-HSCs with concentrated lentivirus of a Socs3 shRNA or a Ctrl shRNA, both of which contain GFP reporters. Then the transduced cells were collected and injected into the irradiated recipient wild-type mice. Six weeks later, the number of granulocytic progenitors and mature neutrophils was measured by FACS. Consistently with the results of in vitro CFU assay, we found that mice transduced with Socs3 shRNAs had significantly more GFP+ bone marrow neutrophils than those transduced with Ctrl shRNAs (Fig 8A). However, the number of GFP+ granulocytic progenitor CMPs and GMPs was not affected after Socs3 inhibition (Fig 8B). Furthermore in vivo BrdU-pulsing assays showed that BrdU incorporation of GFP+ CMPs and GFP+ GMPs did not change after Socs3 knockdown (Fig 8C). Taken together, both in vitro and in vivo experiments successfully rescue the decelerated neutrophil development caused by miR-125a deficiency and further confirm that Socs3 is the main factor of regulating neutrophil development from GMPs to mature neutrophils rather than earlier progenitors in MiR125a deficient hematopoiesis.
Previous studies have demonstrated that ectopic expression of miR-125a contributes to expansion of hematopoietic stem cell pool [32,33]. However, we found an unexpected observation that the numbers of other mature hematopoietic lineage cells were not affected besides neutrophils in MiR125a knockout mice (Table 1). These inconsistent results might be explained by the reason that over-expression experiments may lead to gain-of-function phenotypes which cannot be found in knockout mice. Therefore, our results show miR-125a has an indispensable role in regulating neutrophil production. Neutrophils as well as monocytes-macrophages are the first line of defense in response to systemic inflammation caused by pathogen infection or injury. Under endotoxin challenge, monocytes-macrophages release inflammatory factors such as TNF-α recruiting neutrophils in several organs to mediate tissue destruction [26]. Depletion of neutrophils protects the liver against injury from endotoxin [34]. Thus, like monocyte-macrophages, neutrophils also play a crucial role in endotoxemia. Our study reveals that MiR125a-/- mice have decreased numbers of neutrophils compared to wild-type mice. In addition, in our LPS shock model, we observed resistance to a lethal dose of LPS in MiR125a-/- mice but the concentration of TNF-α and IL-6 in the serum remained unchanged compared to control mice. Furthermore, macrophage reconstitution experiments indicated that macrophages did not contribute to resistance to LPS shock in MiR125a-/- mice. Therefore, we eliminated the possibility that MiR125a-/- macrophages exhibited less cytokine production in response to stimulation of Toll-like receptors. Importantly, we found less neutrophil infiltration in the lungs and alleviated multiple organ damage in MiR125a-/- mice after LPS challenge. As we also detected MiR125a-/- neutrophils were as mature and functional as those in wild-type mice. Therefore, we deduced that resistance to a lethal dose of LPS in MiR125a-/- mice was mainly due to reduced neutrophil numbers in granulopoiesis. Granulopoiesis is part of hematopoiesis that maintains the peripheral neutrophil pool steady. In our study, we found MiR125a knockout mice showed neutropenia. We considered the main reason for the neutropenia was probably due to decreased cell proliferation from granulocyte progenitors to mature neutrophils in MiR125a-/- mice. The following are the main evidences demonstrated in this paper. Firstly, numbers of myeloid progenitors including CMPs and GMPs do not change according to FACS and CFU analyses, suggesting miR-125a may not regulate GMPs or even earlier progenitors. Secondly, the colony size is smaller and the cell number per colony is decreased from MiR125a-deficient GMPs, implying miR-125a involves in the respectively late stage of granulocyte development. Thirdly, immature and mature neutrophils are incorporated less BrdU in MiR125a KO mice while BrdU-incorporating promyelocytes/myelocytes have no change, meaning that miR-125a mediates cell proliferation during the differentiation from immature neutrophils to mature neutrophils. In addition, there is no difference in the rate of cell death between MiR125a-/- and wild-type mice by staining with Annexin V and propidium iodide, excluding the possibility that miR-125a-mediated cell death of neutrophils. Furthermore, other granulocytes (eosinophils and basophils) are not affected in MiR125a knockout mice (Table 1) also indicating that miR-125a is specific for regulating immature neutrophils rather than affecting earlier common granulocyte precursors. To investigate the molecular mechanism of miR-125a in regulating neutrophil development, we checked the activation of G-CSF signaling pathway in wild-type and MiR125a deficient neutrophils. G-CSF is the major growth factor during each developmental stage of granulopoiesis [35]. STAT3, STAT1 and ERK are downstream transcription factors in G-CSF signaling [36]. From western blot analysis, we found MiR125a deficiency mainly caused impaired G-CSF signaling pathway through weakening the phosphorylation ratio of downstream transcription factors. But it made us a little bit confused. Although the phosphorylation ratio of STAT3 was reduced, phospho-STAT3 was moderately enhanced while total STAT3 was much higher in MiR125a-/- neutrophils. In order to solve this problem, we used STAT3 inhibitor S3I-201 in GMP CFU assays. Results demonstrated that inhibiting STAT3 cannot rescue the decelerated differentiation from MiR125a-/- GMP. Thus we deduce that the phenomenon of the enhanced total STAT3 might be through other unknown mechanisms and it is unlikely to mediate decreased granulocyte differentiation in MiR125a-/- mice. Owing to the weak G-CSF signaling in MiR125a-deficient mice, we deduce that miR-125a might target a repressor in this pathway. SOCS3 is the principal suppressor of G-CSF signaling. It can bind to pY729 of the G-CSF receptor and directly inhibit receptor binding to JAKs, thus repressing downstream signaling [30,31,37]. Particularly the mice in which Socs3 is conditionally knocked-out in bone marrow have increased neutrophil number and enhanced cellular responses to G-CSF including an increase in proliferative capacity [10,11]. In our study, we actually identified Socs3 as a direct target of miR-125a. And the expression of Socs3 was indeed enhanced in MiR125a-/- neutrophils, weakening G-CSF signaling and eventually reducing neutrophils differentiation (S6 Fig). Furthermore, both in vivo and in vitro rescue experiments demonstrated that Socs3 indeed was the main target of miR-125a to regulate late stage development of neutrophils rather than earlier progenitors. Nevertheless, we deduce that miR-125a promotes granulopoiesis mainly by targeting suppressor Socs3. MiRNAs are abundant regulators of transcriptional programs. They serve as fine-tuners of biological systems by giving signaling pathways a threshold to protect from unwanted or wrong signals and making signal output more precise and appropriate [38]. In many signaling pathways, the expression of miRNAs can be induced or repressed in response to outside stimuli and form feed-forward or feedback mechanisms with other signaling components [13]. However, basal expression of miRNAs is important for cell-type-specific gene expression through acting as switches like transcriptional factors during cell lineage determination [39]. Hematopoietic lineage differentiation is also switched by miRNAs. For example, miR-150 for B cell [18–20], megakaryocytic and erythrocytic lineage commitment [21], and miR-223 for granulocytic differentiation [22,23]. In this paper, we proposed a model that miR-125a served as a positive regulator of physiological granulopoiesis by amplifying G-CSF signal strength and duration. In order to get a view of the regulation of miR-125a, we examined whether the expression of miR-125a was also affected by G-CSF signaling. However, we did not detect a significant change of the expression of miR-125a in granulocytes after G-CSF stimuli. As we found that miR-125a was decreased during maturation of granulocytes, we detected the expression of its target Socs3 which was also down-regulated and the expression of miR-125a and its target Socs3 exhibited a positive correlation in granulocyte development (S7 Fig). Although this kind of correlation between miRNA and its targets is against the repressive nature of miRNA-mediated gene regulation, bioinformative analysis shows that it is prevalent [40]. Because miRNAs often repress target genes through translational inhibition and have minor effects on target mRNA levels, so miRNAs and their targets levels are mainly controlled by upstream transcription factors [40]. According to this model, both Socs3 and miR-125a are down-regulated during granulopoiesis and down-regulated miR-125a leads to up-regulated Socs3 as a feed-forward signal. Thus this circuit can tune upstream signal fluctuation and eventually maintain SOCS3 protein homeostasis. As Socs3 is a critical negative regulator of granulopoiesis, its level in progenitors of granulocytes can affect the neutrophils differentiation and any significant change may lead to pathological consequences, namely neutrophilia and neutropenia. From this view, miR-125a modulation eventually provides a steady device to maintain differentiation and homeostasis of neutrophils rather than to simply repress the expression of Socs3. In conclusion, we showed that miR-125a can positively regulate granulopoiesis. We demonstrated that miR-125a positively regulated G-CSF-dependent proliferation during the development of granulocytes by targeting Socs3. Our findings reveal a new microRNA involving granulocyte development and provide insights into the function of miR-125a during hematopoiesis. Future genetic studies will focus on how miR-125a is regulated during hematopoietic development.
MiR125a knockout mice were generated as previously described [25] and maintained under specific pathogen–free conditions at Institute of Health Sciences, Chinese Academy of Sciences animal breeding facility, according to institute guidelines. 8 to 12-week-old MiR125a knockout mice and their littermate controls were used for experiments. All experiments involving mice were in accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals of 1988, issued by the State Scientific and Technological Commission for China. And these experiments were approved by the Biomedical Research Ethics Committee of the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. To analyze neutrophils, single cell suspensions of bone marrow or peripheral blood or spleen were stained with CD11b PerCP-Cyanine5. 5 (eBioscience 45-0112-82) and Ly-6G-APC (eBioscience 17-5931-82). To measure neutrophil infiltration in the lung, lung tissues were cut into very small fragments and digested by collagenase and DNase I for 20 minutes at 37°C. Single cell suspensions were then stained with CD45-FITC (BD pharmingen, 553080), Ly-6G-APC and CD11b PerCP-Cy5. 5. To detect the myeloid progenitor cells, bone marrow cells were pre-stained with biotin-conjugated mouse lineage panel (BD pharmingen, 559971), and then stained with streptavidin-V450 (BD horizon, 560797), Sca-1-PE-Cy7 (BD pharmingen, 558162), c-Kit-PE (BD pharmingen, 553355), CD34-FITC (BD pharmingen, 560238) and CD16/32-APC (eBioscience, 17-0161-82). Flow cytometry was conducted on a FACS Aria (BD Biosciences). The recipient mice were fed with acidic (pH 2. 6), antibiotic water for one week before irradiation and then were given 8. 0 Gy irradiation by using a 137Cesium Gammacell source. 4 hours later, the mice were injected with 2x107 bone marrow cells from the donor mice via tail vein and then were kept on giving acidic antibiotic water for the rest of their lives. To sort hematopoietic stem cells and progenitor cells, bone marrow cells were pre-enriched by depleting lineage positive cells (Stemcell, 19756). Hematopoietic stem cells were then sorted by Sca1+c-Kit+Lin-. CMPs were sorted by Sca1-c-kit+Lin-CD34+CD16/32-. GMPs were sorted by Sca1-c-kit+Lin-CD34+CD16/32+ and MEPs were sorted by Sca1-c-kit+Lin-CD34-CD16/32-. The purity of each cell population reached 95%. Neutrophils were isolated from bone marrow or peritoneal cavity by using the Neutrophil Isolation Kit (Miltenyi Biotec, 130-097-658). The purity of the isolated neutrophils was about 90%, as determined by flow cytometry. Total RNA was isolated using TRIzol reagent (Life technologies). RNA quality was assessed with an Agilent 2100 Bioanalyzer (Agilent), and only samples with an RNA integrity number > 8 were used. Global mRNA expression in bone marrow neutrophils with or without LPS stimulation samples from and MiR125a+/+ and MiR125a-/- mice were assayed with the Affymetrix GeneChip Mouse Genome 430 2. 0 Array. Data were deposited in GEO (GSE63739, http: //www. ncbi. nlm. nih. gov/geo/query/acc. cgi? acc=GSE63739) and analyzed with R and the associated BioConductor packages. Isolated bone marrow neutrophils were resuspended in 0. 1% BSA 1X Hanks balanced salt solution containing calcium and magnesium (Gibco) and plated in 3 μm Transwells (1X105 cells per Transwell, Corning) in the absence or presence of the indicated chemokine in the lower chamber (0. 1 mM fMLP, Sigma; 250 ng/mL MIP-2, Peprotech; 1μg/mL KC, Peprotech). After incubation at 37°C for 3 hours, numbers of cell that migrated through transwell were counted. Isolated bone marrow neutrophils were incubated in the presence of 1 μM dihydrorhodamine (Sigma) during stimulation with different concentrations of PMA (Sigma) for 15 minutes or LPS for 4 hours (Sigma). The oxidative burst of neutrophils was then analyzed by flow cytometry. 2x105 Candida albicans strain SC5314 or 1x107 Citrobacter rodentium were incubated with or without 5x105 bone marrow neutrophils in flat-bottom 96-well plates for 4 hours. Then all wells were treated with 0. 02% triton-X 100 in PBS for 5 minutes. Surviving bacteria or fungi were incubated with 10μl MTT (5mg/mL) for 4 hours at 37°C then formazans were dissolved in DMSO and fluorescence was measured at 570 nm absorption wavelength. Total RNA was isolated with TRIzol reagent (Life Technology). Expression of microRNAs in sorted cell populations was determined by quantitative PCR using the TaqMan MicroRNA Assay (Applied Biosystems). MicroRNA expression was normalized to snoRNA202. Socs3, Il6, Tnfa, Gcsfr, Pu. 1, Gata-1, Cebpa, Cebpb and Cebpe mRNA expression levels were quantified by using SYBR PrimeScript reverse-transcription–PCR kit (Takara). Expression levels were normalized to endogenous expression of Gapdh. Wild-type mice were first depleted of endogenous macrophages by pre-treatment with 100 μl clodronate liposome Clophosome-A (FormuMax Scientific) on Day1 and Day2. On Day3, these mice were transplanted with 1x107 MiR125a +/+ or MiR125a -/- bone marrow-derived macrophages. Macrophage depletion was detected by flow cytometry on Day3 and Day6 and the spleen and bone marrow macrophages were depleted >90%. To count the number of GMPs, 5x104 bone marrow cells were cultured in methylcellulose (Mouse Methylcellulose Base Medium, R&D Technologies) added to various concentrations of recombinant murine G-CSF (R&D Technologies). After 10 days, colony numbers were counted. To quantify multi-potential progenitors and lineage-restricted progenitors, 2x104 bone marrow cells were plated in complete methylcellulose medium (Stemcell, 03434). After 12 days, colonies were counted and analyzed morphologically. Bone marrow cells were cultured in 10% FBS RPMI 1640 medium (Life Technologies) for 48 hours, washed and stained for Ly-6G-APC and Annexin V FITC and PI (BD Biosciences) and analyzed by flow cytometry. For the in vivo BrdU-incorporation experiment, mice aged 8–10 weeks were intraperitoneally injected with 200 μl of a 10mg/mL BrdU solution. After 3 days, mice were sacrificed and the spleen and bone marrow cells were harvested to detect BrdU-positive neutrophils. For in vitro BrdU-labeling of cells, bone marrow neutrophils were isolated and stimulated with 100 ng/ml G-CSF for 24 hours followed by incubating cells with 10 μM BrdU for 1 hour. BrdU-positive neutrophils were detected by using the BrdU flow kit from Pharmingen (BD Biosciences, 559619) with a FITC-labeled anti-BrdU antibody. Neutrophils were stained with CD11b-Percp Cy5. 5 and Ly-6G-APC before fixation and permeabilization of the cells. TNF-α and IL-6 in mice serum were detected by R&D Technologies duo set ELISA kit. For immunoblotting experiments, bone marrow cells or neutrophils were lysed with RIPA buffer and blotted with indicated antibodies. P-STAT3, STAT3, p-STAT1, STAT1, p-ERK, ERK and SOCS3 were all purchased from Cell Signaling Technology. GAPDH antibodies were obtained from Abcam. To test whether miR-125a directly target the Socs3 3′ UTR, 293T cells were plated in 96-well plates and transfected with 10 ng wild-type or mutant Socs3 3′ UTR and the synthetic miR-125a oligonucleotide or negative control oligonucleotide by using Lipofectamine 2000 reagent (Invitrogen). Firefly and renilla luciferase activities were determined after 24 hours using the Dual-Luciferase Reporter Assay System (Promega). The values were normalized to firefly luciferase. To generate a retrovirus construct, MSCV-LTR miR30-PIG (LMP) plasmids were cloned into Socs3-specific hairpin RNA. The target sequence is as follows: CGC GAG TAC CAG CTG GTG GTG A. Plate-E cells were transfected with 30ug LMP shRNA for a dish and retroviruses were harvested from culture supernatant after 48 hours. Mice bone marrow cells were depleted lineage positive cells by magnetic beads, stimulated with G-CSF overnight, then infected with recombinant retrovirus. 48 hours later, green fluorescent protein expressing GMPs were sorted for CFU assays. To generate a lentivirus construct, pLVX-shRNA2 plasmids were cloned into Socs3-specific hairpin RNA. The target sequence is the same as above. 293T cells were transfected with 15ug pLVX-shRNA2 together with 8ug pMD2. G and 15ug psPAX2 plasmids for one dish. Lentivirus were harvested and concentrated from culture supernatant after 72 hours. Bone marrow cells of MiR125a ko mice were depleted lineage positive cells by magnetic beads, and short-term hematopoietic stem cells (ST-HSC) were sorted by sca-1+c-kit+CD135-CD34+ and resuspended at 1 x 104 in 75 uL StemSpan (StemCell Technologies), supplemented with 50 ng/ml SCF (Peprotech) in a round-bottomed well of a 96-well plate. 2. 5 x 107 units of lentivirus were added into each well after 2 hours, predetermined to give about 20% transduction efficiency by measuring of GFP positive cells in pilot experiments. Then plates were spun at 900g for 90 min, and cultured at 37°C with 5% CO2-in-air. Cells were collected and washed after 4. 5 hours and per 1. 5 x 10^4 ST-HSCs were resuspended in 250 ul PBS which was then injected into each irradiated recipient wild-type mouse.
MicroRNAs are critical epigenetic modulators in development, physiology and disease processes. Many miRNAs are involved in immune cell development and function, like miR-150 for B cells, miR-181a for T cells. However, studies of miRNAs involvement in granulocyte development and function and related diseases are still limited. In this study, we developed engineering MiR125a knockout mice to study the function of miR-125a in vivo. We identified MiR125a knockout mice had decreased neutrophil numbers and reduced infiltration of neutrophils in the lung in LPS shock model. We deduced that this significant reduction of neutrophils was due to impaired development of granulocyte precursors to mature neutrophils in an intrinsic manner. Furthermore, we demonstrated that Socs3, a major repressor that negatively regulates granulocyte development, was a target of miR-125a. This finding not only reveals a new microRNA involving granulocyte development, but also provides insights into the new mechanism of miR-125a during action in endotoxemia.
blood cells
flow cytometry
medicine and health sciences
immune cells
gene regulation
immunology
bone marrow cells
animal models
micrornas
model organisms
granulocytes
experimental organism systems
neutrophils
research and analysis methods
white blood cells
animal cells
gene expression
mouse models
stat signaling
spectrophotometry
biochemistry
rna
cytophotometry
signal transduction
cell biology
nucleic acids
genetics
biology and life sciences
cellular types
macrophages
non-coding rna
cell signaling
spectrum analysis techniques
MiR-125a Is a critical modulator for neutrophil development